Forskolin

規格

66575-29-9CAS番号

266-410-9EC番号

[(3R,4aR,5S,6S,6aS,10S,10aR,10bS)-3-ethenyl-6,10,10b-trihydroxy-3,4a,7,7,10a-pentamethyl-1-oxo-5,6,6a,8,9,10-hexahydro-2H-benzo[f]chromen-5-yl] acetateIUPAC名

C22H34O7化学式

410.5 g/mol分子量

forskolin; Colforsin; 66575-29-9; Coleonol; colforsina; colforsine; Boforsin; colforsinum; Coleonolk; HL 362; L 75 1362B; DTXSID8040484; HL-362; 1F7A44V6OU; L-751362B; 7beta-Acetoxy-8,13-epoxy-1alpha,6beta,9alpha-trihydroxylabd-14-en-11-one; NSC-357088; NSC-375489; (3R,4aR,5S,6S,6aS,10S,10aR,10bS)-3-ethenyl-6,10,10b-trihydroxy-3,4a,7,7,10a-pentamethyl-1-oxododecahydro-1H-benzo[f]chromen-5-yl acetate; [(3R,4aR,5S,6S,6aS,10S,10aR,10bS)-3-ethenyl-6,10,10b-trihydroxy-3,4a,7,7,10a-pentamethyl-1-oxo-5,6,6a,8,9,10-hexahydro-2H-benzo[f]chromen-5-yl] acetate; DTXCID6020484; L-75-1362B; CHEBI:42471; (3R,4aR,5S,6S,6aS,10S,10aR,10bS)-3-ethenyl-6,10,10b-trihydroxy-3,4a,7,7,10a-pentamethyl-1-oxo-dodecahydro-1H-naphtho[2,1-b]pyran-5-yl acetate; ((3R,4aR,5S,6S,6aS,10S,10aR,10bS)-3-ethenyl-6,10,10b-trihydroxy-3,4a,7,7,10a-pentamethyl-1-oxo-5,6,6a,8,9,10-hexahydro-2H-benzo(f)chromen-5-yl) acetate; (3R,4aR,5S,6S,6aS,10S,10aR,10bS)-3-ethenyl-6,10,10b-trihydroxy-3,4a,7,7,10a-pentamethyl-1-oxo-dodecahydro-1H-naphtho(2,1-b)pyran-5-yl acetate; (3R,4aR,5S,6S,6aS,10S,10aR,10bS)-3-ethenyl-6,10,10b-trihydroxy-3,4a,7,7,10a-pentamethyl-1-oxododecahydro-1H-benzo(f)chromen-5-yl acetate; RefChem:578508; 266-410-9; N,N-dimethyl-beta-alanine-5-(acetyloxy)-3-ethenyldodecahydro-10,10b-dihydroxy-3,4a,7,7,10a-pentamethyl-1-oxo-1H-naphtho(2,1-b)pyran-6-yl ester HCl; (-)-Forskolin; MFCD00082317; (3R,4aR,5S,6S,6aS,10S,10aR,10bS)-6,10,10b-trihydroxy-3,4a,7,7,10a-pentamethyl-1-oxo-3-vinyldodecahydro-1H-benzo[f]chromen-5-yl acetate; Forskolin (GMP); CHEMBL52606; 66428-89-5; NSC375489; NCGC00024996-02; 64657-11-0; (3R,4aR,5S,6S,6aS,10S,10aR,10bS)-5-(Acetyloxy)-3-ethenyldodecahydro-6,10,10b-trihydroxy-3,4a,7,7,10a-pentamethyl-1H-naphtho[2,1-b]pyran-1-one; (3R,4aR,5S,6S,6aS,10S,10aR,10bS)-Dodecahydro-5,6,10,10b-tetrahydroxy-3,4a,7,7,10a-pentamethyl-3-vinyl-1H-naphtho(2,1-b)pyran-1-one 5-acetate; Colforsine [French]; Colforsinum [Latin]; Colforsina [Spanish]; Coleonol;Colforsin; ForsLean; Colforsin [USAN:INN]; [(3R,4aR,5S,6S,6aS,10S,10aR,10bS)-6,10,10b-trihydroxy-3,4a,7,7,10a-pentamethyl-1-oxo-3-vinyl-5,6,6a,8,9,10-hexahydro-2H-benzo[f]chromen-5-yl] acetate; 1H-Naphtho[2,1-b]pyran-1-one, 5-(acetyloxy)-3-ethenyldodecahydro-6,10,10b-trihydroxy-3,4a,7,7,10a-pentamethyl-, (3R,4aR,5S,6S,6aS,10S,10aR,10bS)-; FOK; SMR000471881; CAS-66575-29-9; EINECS 266-410-9; NSC 357088; NSC 375489; UNII-1F7A44V6OU; Forscoline; Ocufors; Forskolin?; Timsaponin-C; (3R,4aR,5S,6S,6aS,10S,10aR,10bS)-Dodecahydro-5,6,10,10b-tetrahydroxy-3,4a,7,7,10a-pentamethyl-3-vinyl-1H-naphtho[2,1-b]pyran-1-one 5-acetate; Forskolin (Standard); COLFORSIN [INN]; COLFORSIN [MI]; Colforsin (USAN/INN); COLFORSIN [USAN]; FORSKOLIN [VANDF]; COLFORSIN [MART.]; MolMap_000021; 7-beta-Acetoxy-8,13-epoxy-1-alpha,6-beta,9-alpha-trihydroxylabd-14-en-11-one; COLFORSIN [WHO-DD]; FORSKOLIN [USP-RS]; SCHEMBL4928; cid_47936; MLS001066384; MLS001333255; MLS001333256; MLS002172462; MLS002695942; Forskolin, analytical standard; Forskolin - Bio-X trade mark; REGID_for_CID_47936; GTPL5190; BCBcMAP01_000132; OHCQJHSOBUTRHG-KGGHGJDLSA-; Bio1_000443; Bio1_000932; Bio1_001421; GLXC-05197; HMS2235C17; HMS3267I16; HMS3412G19; HMS3676G19; EX-A5963; Tox21_110940; Tox21_302399; BDBM50010261; HB1348; HY-15371G; HY-15371R; s2449; AKOS024456384; Tox21_110940_1; CCG-268774; CS-1454; DB02587; EBC-157221; FF23593; LMPR0104030004; SMP1_000128; NCGC00024996-03; NCGC00024996-04; NCGC00024996-05; NCGC00024996-06; NCGC00024996-07; NCGC00024996-10; NCGC00024996-34; NCGC00177971-03; NCGC00255526-01; [(3R,4aR,5S,6S,6aS,10S,10aR,10bS)-3-ethenyl-6,10,10b-trihydroxy-3,4a,7,7,10a-pentamethyl-1-oxo-5,6,6a,8,9,10-hexahydro-2H-benzo[f]chromen-5-yl]acetate; 1H-Naphtho(2,1-b)pyran-1-one, 5-(acetyloxy)-3-ethenyldodecahydro-6,10,10b-trihydroxy-3,4a,7,7,10a-pentamethyl-; 1H-Naphtho(2,1-b)pyran-1-one, 5-(acetyloxy)-3-ethenyldodecahydro-6,10,10b-trihydroxy-3,4a,7,7,10a-pentamethyl-, (3R-(3alpha,4abeta,5beta,6beta,6aalpha,10alpha,10abeta,10balpha))-; 1H-Naphtho(2,1-b)pyran-1-one, dodecahydro-5-(acetyloxy)-3-ethenyl-3,4a,7,7,10a-pentamethyl-6,10,10b-trihydroxy-, (3R-(3-alpha,4a-beta,5-beta,6-beta,6a-alpha,10-alpha,10a-beta,10b-alpha))-; 5-(Acetyloxy)-3-ethenyldodecahydro-6,10,10b-trihydroxy-3,4a,7,7,10a-pentamethyl-1H-naphtho(2,1-b)pyran-1-one; AC-33150; AS-17443; BF164487; FF170900; HY-15371; SY076754; CS-0622781; F0855; F5668; M-410; NS00020690; T2939; C09076; D03584; M04088; MLS-0318096.0001; Q412747; SR-01000597378; FORSKOLIN (CONSTITUENT OF FORSKOHLII) [DSC]; Forskolin, For use in molecular biology applications; SR-01000597378-1; BRD-K09602097-001-04-5; BRD-K09602097-001-13-6; Z1395264745; Forskolin, from Coleus forskohlii, >=98% (HPLC), powder; Forskolin, United States Pharmacopeia (USP) Reference Standard; 7beta-acetoxy-1alpha,6beta,9alpha-trihydroxy-8,13-epoxy-labd-14-en-11-one; (3R,4?R,5S,6S,6?S,10S,10?R,10?S)-5-(Acetyloxy)-3-ethenyldodecahydro-6,10,10?-trihydroxy-3,4?,7,7,10?-pentamethyl-1H-naphtho[2,1-?]py ran-1-one; (3R,4aR,5S,6S,6aS,10S,10aR,10bS)-3-Ethenyl-6,10,10b-trihydroxy-3,4a,7,7,10a-pentamethyl-1-oxododecahydro-1H-naphtho[2,1-b]pyran-5-yl acetate; [3R-(3<I<<,4aEC,5EC,6EC,6aI<<,10I<<,10aEC,10bI<<)]-5-(Acetyloxy)-3-ethenyldodecahydro-6,10,10b-trihydroxy-3,4a,7,7,10a-pentamethyl-1H-naphtho[2,1-b]pyran-1-one; [3R-(3a,4ab,5b,6b,6aa,10a,10ab,10ba)]-5-(Acetyloxy)-3-e thenyldodecahydro-6,10,10b-trihydroxy-3,4a,7,7,10a-pentamethyl-1H-naphtho[2,1-b]pyran-1-one; 7beta-acetoxy-8,13-epoxy-1alpha,6beta,9alpha-trihydroxylabd-14-en-11-one; FORSKOLIN; colforsina; colforsine; colforsinum; InChI=1/C22H34O7/c1-8-19(5)11-14(25)22(27)20(6)13(24)9-10-18(3,4)16(20)15(26)17(28-12(2)23)21(22,7)29-19/h8,13,15-17,24,26-27H,1,9-11H2,2-7H3/t13-,15-,16-,17-,19-,20-,21+,22-/m0/s1別名